当前位置: 首页 >> 检索结果
141. Gender Equity in Gastroenterology: Perspectives From the AGA Women's Committee on Current Frameworks and Future Directions.
作者: Loren G Rabinowitz.;Kira Newman.;Elisa Boden.;Blaire Burman.;Asma Khapra.;Aimee L Lucas.; .
来源: Gastroenterology. 2025年169卷2期195-199页 142. Correction: Accuracy of the diagnosis of gastroesophageal reflux disease by a trial of potassium-competitive acid blocker treatment.
作者: Peiwen Dong.;Lin Lin.;Kaidi Sun.;Feng Tang.;Qian Li.;Xinxu Zhou.;Fuli Liu.;Zhilin Yang.;Jiao Li.;Lin Jiang.;Ping Zhao.;Xiaobin Sun.;Qiong Wang.
来源: BMC Gastroenterol. 2025年25卷1期530页 144. Mild Crohn's Disease Is Associated With Altered Sphingolipid Metabolism and Reduced Neutrophilic Inflammation.
作者: Arno R Bourgonje.;Susanne Ibing.;Palak Rajauria.;Jellyana Peraza.; .;Jean-Frédéric Colombel.;Ryan C Ungaro.
来源: Gastroenterology. 2025年 145. Early Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UC.
作者: Christopher F D Li Wai Suen.;Matthew C Choy.;Danny Con.;Kaylene Cheng.;Julie Nigro.;Kerry Breheney.;Kristy Boyd.;Raquel Pena.;Kathryn Burrell.;Ourania Rosella.;David Proud.;Richard Brouwer.;Alexandra Gorelik.;Danny Liew.;William Connell.;Emily K Wright.;Kirstin Taylor.;Aviv Pudipeddi.;Michelle Sawers.;Britt Christensen.;Watson Ng.;Jakob Begun.;Graham L Radford-Smith.;Mayur Garg.;Neal Martin.;Daniel R van Langenberg.;Nik S Ding.;Lauren Beswick.;Rupert W Leong.;Miles P Sparrow.;Christina Grosserichter-Wagener.;Henk Te Velthuis.;Kumar Visvanathan.;Peter De Cruz.
来源: Gastroenterology. 2025年
The role of infliximab therapeutic drug monitoring in acute severe ulcerative colitis (ASUC) management is unknown. We aimed to identify whether infliximab therapeutic drug monitoring is associated with ASUC outcomes.
148. Sex-specific adverse effects of lipid accumulation products and cardiometabolic indices on the prevalence of gallstones: insights from the 2017-2020 national health and nutrition examination survey.
作者: Yangyang Zheng.;Xiaoli Chen.;Yunpeng Ge.;Haowei Shi.;Shiqi Guo.;Wendan Tan.;Jinghai Song.
来源: BMC Gastroenterol. 2025年25卷1期529页
Anthropometric measurements and lipid profiles are associated with the onset of gallstone disease, with these associations exhibiting sex-specific variations. This study investigated the association between the prevalence of gallstones and two anthropometric-lipid markers, namely Lipid Accumulation Products (LAP) and Cardiometabolic Index (CMI), while also assessing the presence of sex disparities.
151. Global burden of esophageal diseases: a comprehensive analysis of disease trends and risk factors from 1990 to 2021.
作者: Yanbin Wei.;Endian Liu.;Jiafei Peng.;Yanqing Liu.;Xiujing Sun.;Xin Yao.
来源: BMC Gastroenterol. 2025年25卷1期528页
Esophageal diseases (ED) are a common category of upper gastrointestinal disorders, mainly including gastroesophageal reflux disease (GERD), esophagitis, Barrett's esophagus, achalasia, and esophageal cancer (EC). In recent years, the high recurrence rate of GERD and poor prognosis of EC are paid more attention, collectively contributing to the global burden of ED.
152. Development and validation of predictive models for disease-free survival and overall survival in non-metastatic right-sided colon adenocarcinoma patients based on inflammatory and nutritional indices.
This study developed and validated prognostic nomograms incorporating inflammatory and nutritional biomarkers to predict disease-free survival (DFS) and overall survival (OS) in patients with non-metastatic right-sided colon adenocarcinoma (NRCA).
155. The effect of neoadjuvant chemoradiation therapy in resectable pancreatic cancer was independent of intratumoral vascularization.
作者: Tomomi Yasue.;Reiko Ashida.;Ryoji Takada.;Kenji Ikezawa.;Kazuyoshi Ohkawa.;Shigenori Nagata.;Teruki Teshima.;Hirofumi Akita.;Hidenori Takahashi.;Yuichiro Doki.;Hidetoshi Eguchi.
来源: BMC Gastroenterol. 2025年25卷1期526页
Contrast-enhanced harmonic endoscopic ultrasound (CH-EUS) has promising potential in the diagnosis of pancreatic tumors, assessment of fibrosis, and prediction of chemotherapy efficacy. We hypothesize that radiation therapy might reduce variations in chemotherapeutic efficacy caused by fibrosis-induced blood flow disparities, as we explored the relationship between CH-EUS patterns and the efficacy of neoadjuvant chemoradiotherapy (NACRT) in resectable pancreatic cancer (PC).
159. AGA Clinical Practice Update on Incorporating Functional Lumen Imaging Probe Into Esophageal Clinical Practice: Expert Review.
作者: Anh D Nguyen.;Dustin A Carlson.;Amit Patel.;C Prakash Gyawali.
来源: Gastroenterology. 2025年169卷4期726-736.e1页
The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update (CPU) is to summarize the available evidence and offer expert best practice advice on the incorporation of the functional lumen imaging probe (FLIP) into clinical practice, specifically its utility in the evaluation of esophageal symptoms, esophageal motor dysfunction, gastroesophageal reflux disease, and eosinophilic esophagitis.
160. The effectiveness of combining ursodeoxycholic acid with vitamin D in treating patients with primary biliary cholangitis and its impact on hepatic fibrosis: a randomized trial.
作者: Yilihamu Abulitifu.;Mierzhati Maimaiti.;Fengcong Zhao.;Munire Adilijiang.;Wen Qian.;Yongping Zhang.
来源: BMC Gastroenterol. 2025年25卷1期525页
To investigate the effectiveness of combining ursodeoxycholic acid (UDCA) and vitamin D (VitD) in treating patients with primary biliary cholangitis (PBC) and its impact on hepatic fibrosis.
|